• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于卵巢癌研究的体内模型系统的特征

Characteristics of in Vivo Model Systems for Ovarian Cancer Studies.

作者信息

Tudrej Patrycja, Kujawa Katarzyna Aleksandra, Cortez Alexander Jorge, Lisowska Katarzyna Marta

机构信息

Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie Institute - Oncology Center, Gliwice Branch, ul. Wybrzeże Armii Krajowej 15, 44-101 Gliwice, Poland.

出版信息

Diagnostics (Basel). 2019 Sep 14;9(3):120. doi: 10.3390/diagnostics9030120.

DOI:10.3390/diagnostics9030120
PMID:31540126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6787695/
Abstract

An understanding of the molecular pathogenesis and heterogeneity of ovarian cancer holds promise for the development of early detection strategies and novel, efficient therapies. In this review, we discuss the advantages and limitations of animal models available for basic and preclinical studies. The fruit fly model is suitable mainly for basic research on cellular migration, invasiveness, adhesion, and the epithelial-to-mesenchymal transition. Higher-animal models allow to recapitulate the architecture and microenvironment of the tumor. We discuss a syngeneic mice model and the patient derived xenograft model (PDX), both useful for preclinical studies. Conditional knock-in and knock-out methodology allows to manipulate selected genes at a given time and in a certain tissue. Such models have built our knowledge about tumor-initiating genetic events and cell-of-origin of ovarian cancers; it has been shown that high-grade serous ovarian cancer may be initiated in both the ovarian surface and tubal epithelium. It is postulated that clawed frog models could be developed, enabling studies on tumor immunity and anticancer immune response. In laying hen, ovarian cancer develops spontaneously, which provides the opportunity to study the genetic, biochemical, and environmental risk factors, as well as tumor initiation, progression, and histological origin; this model can also be used for drug testing. The chick embryo chorioallantoic membrane is another attractive model and allows the study of drug response.

摘要

了解卵巢癌的分子发病机制和异质性有望推动早期检测策略以及新型高效疗法的发展。在本综述中,我们讨论了可用于基础研究和临床前研究的动物模型的优缺点。果蝇模型主要适用于细胞迁移、侵袭、黏附以及上皮-间质转化的基础研究。高等动物模型能够重现肿瘤的结构和微环境。我们讨论了同基因小鼠模型和患者来源的异种移植模型(PDX),这两种模型都对临床前研究有用。条件性基因敲入和敲除方法能够在特定时间和特定组织中操纵选定的基因。此类模型增进了我们对卵巢癌起始遗传事件和起源细胞的了解;研究表明,高级别浆液性卵巢癌可能起源于卵巢表面上皮和输卵管上皮。据推测,可以开发非洲爪蟾模型,用于研究肿瘤免疫和抗癌免疫反应。在蛋鸡中,卵巢癌会自发发生,这为研究遗传、生化和环境风险因素以及肿瘤的起始、进展和组织学起源提供了机会;该模型也可用于药物测试。鸡胚绒毛尿囊膜是另一个有吸引力的模型,可用于研究药物反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/d6d0033159e3/diagnostics-09-00120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/44dbcb2c56c6/diagnostics-09-00120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/ae689fe17f30/diagnostics-09-00120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/fc397ce99f29/diagnostics-09-00120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/d6d0033159e3/diagnostics-09-00120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/44dbcb2c56c6/diagnostics-09-00120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/ae689fe17f30/diagnostics-09-00120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/fc397ce99f29/diagnostics-09-00120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f760/6787695/d6d0033159e3/diagnostics-09-00120-g004.jpg

相似文献

1
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies.用于卵巢癌研究的体内模型系统的特征
Diagnostics (Basel). 2019 Sep 14;9(3):120. doi: 10.3390/diagnostics9030120.
2
The promise and challenge of ovarian cancer models.卵巢癌模型的前景与挑战。
Transl Cancer Res. 2015 Feb;4(1):14-28. doi: 10.3978/j.issn.2218-676X.2015.01.02.
3
Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.鸡胚绒毛尿囊膜(CAM)试验作为一种体内模型,用于研究新鉴定分子对卵巢癌侵袭和转移的影响。
Int J Mol Sci. 2012;13(8):9959-9970. doi: 10.3390/ijms13089959. Epub 2012 Aug 10.
4
Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.鸡胚尿囊膜在癌症研究中的应用。
Cells Tissues Organs. 2022;211(2):222-237. doi: 10.1159/000513039. Epub 2021 Mar 29.
5
An orthotopic model of serous ovarian cancer in immunocompetent mice for in vivo tumor imaging and monitoring of tumor immune responses.用于体内肿瘤成像和肿瘤免疫反应监测的免疫健全小鼠浆液性卵巢癌原位模型。
J Vis Exp. 2010 Nov 28(45):2146. doi: 10.3791/2146.
6
The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.鸡胚绒毛尿囊膜(CAM)作为一种用于精准医学和临床前研究的多功能患者来源异种移植(PDX)平台。
Am J Cancer Res. 2018 Aug 1;8(8):1642-1660. eCollection 2018.
7
A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development.一种基于输卵管转化的基因工程卵巢癌小鼠模型模拟了人类高级别浆液性癌的发展。
J Pathol. 2014 Jul;233(3):228-37. doi: 10.1002/path.4353.
8
Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.高级别浆液性卵巢癌的肿瘤筛查、成像及虚拟替身技术进展
Front Oncol. 2014 Nov 18;4:322. doi: 10.3389/fonc.2014.00322. eCollection 2014.
9
Epithelial/mesenchymal heterogeneity of high-grade serous ovarian carcinoma samples correlates with miRNA let-7 levels and predicts tumor growth and metastasis.高级别浆液性卵巢癌样本的上皮/间充质异质性与 miRNA let-7 水平相关,并可预测肿瘤生长和转移。
Mol Oncol. 2020 Nov;14(11):2796-2813. doi: 10.1002/1878-0261.12762. Epub 2020 Aug 21.
10
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.建立用于新型疗法临床前评估的上皮性卵巢癌患者来源的肿瘤异种移植模型。
Clin Cancer Res. 2017 Mar 1;23(5):1263-1273. doi: 10.1158/1078-0432.CCR-16-1237. Epub 2016 Aug 29.

引用本文的文献

1
Therapeutic Potential of Glucose Oxidase-Loaded Biogenic Mesoporous Silica Nanoparticles in Ovarian Cancer.负载葡萄糖氧化酶的生物源介孔二氧化硅纳米颗粒在卵巢癌中的治疗潜力
Pharmaceuticals (Basel). 2025 Jul 18;18(7):1060. doi: 10.3390/ph18071060.
2
Introduction of AGPAT3 gene as a regulator of cisplatin resistance in A2780 ovarian endometrioid carcinoma cell line.AGPAT3基因作为A2780卵巢子宫内膜样癌细胞系中顺铂耐药调节因子的介绍。
PLoS One. 2025 Mar 10;20(3):e0318740. doi: 10.1371/journal.pone.0318740. eCollection 2025.
3
Investigating proteogenomic divergence in patient-derived xenograft models of ovarian cancer.

本文引用的文献

1
Hippo Signaling in Cancer: Lessons From Models.癌症中的河马信号通路:来自模型的经验教训
Front Cell Dev Biol. 2019 May 24;7:85. doi: 10.3389/fcell.2019.00085. eCollection 2019.
2
Current Status of Patient-Derived Ovarian Cancer Models.患者来源的卵巢癌模型的现状。
Cells. 2019 May 25;8(5):505. doi: 10.3390/cells8050505.
3
Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts.卵巢癌患者肿瘤与其来源异种移植瘤配对组织间的基因表达差异。
研究卵巢癌患者来源异种移植模型中的蛋白质基因组差异。
Sci Rep. 2025 Jan 4;15(1):813. doi: 10.1038/s41598-024-84874-3.
4
Avian Models for Human Carcinogenesis-Recent Findings from Molecular and Clinical Research.用于人类致癌研究的禽类模型——分子和临床研究的最新发现。
Cells. 2024 Oct 30;13(21):1797. doi: 10.3390/cells13211797.
5
Beyond 2D cell cultures: how 3D models are changing the study of ovarian cancer and how to make the most of them.超越 2D 细胞培养:3D 模型如何改变卵巢癌的研究以及如何充分利用它们。
PeerJ. 2024 Aug 29;12:e17603. doi: 10.7717/peerj.17603. eCollection 2024.
6
Zebrafish Avatars: Toward Functional Precision Medicine in Low-Grade Serous Ovarian Cancer.斑马鱼化身:迈向低度浆液性卵巢癌的功能精准医学
Cancers (Basel). 2024 May 9;16(10):1812. doi: 10.3390/cancers16101812.
7
DNA Double-Strand Break Repair Inhibitors: YU238259, A12B4C3 and DDRI-18 Overcome the Cisplatin Resistance in Human Ovarian Cancer Cells, but Not under Hypoxia Conditions.DNA双链断裂修复抑制剂:YU238259、A12B4C3和DDRI-18克服人卵巢癌细胞中的顺铂耐药性,但在缺氧条件下无效。
Curr Issues Mol Biol. 2023 Sep 28;45(10):7915-7932. doi: 10.3390/cimb45100500.
8
Dynamic mRNA expression during chicken ovarian follicle development.鸡卵巢卵泡发育过程中的动态 mRNA 表达。
G3 (Bethesda). 2023 Dec 29;14(1). doi: 10.1093/g3journal/jkad237.
9
Microfibril Associated Protein 5 (MFAP5) Is Related to Survival of Ovarian Cancer Patients but Not Useful as a Prognostic Biomarker.微纤维相关蛋白 5(MFAP5)与卵巢癌患者的生存有关,但不能作为预后生物标志物。
Int J Mol Sci. 2022 Dec 15;23(24):15994. doi: 10.3390/ijms232415994.
10
Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer.靶向CSNK2A1的生物活性小干扰RNA的融合肽递送用于卵巢癌治疗
Mol Ther Nucleic Acids. 2022 Sep 19;30:95-111. doi: 10.1016/j.omtn.2022.09.012. eCollection 2022 Dec 13.
Sci Rep. 2019 Apr 19;9(1):6314. doi: 10.1038/s41598-019-42680-2.
4
Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.高级别浆液性卵巢癌的内分泌治疗;疗效的量化和反应预测因子的鉴定。
Gynecol Oncol. 2019 Feb;152(2):278-285. doi: 10.1016/j.ygyno.2018.11.030. Epub 2018 Nov 28.
5
Targeting HER2 in patient-derived xenograft ovarian cancer models sensitizes tumors to chemotherapy.针对源自患者的异种移植卵巢癌模型中的 HER2 可使肿瘤对化疗敏感。
Mol Oncol. 2019 Feb;13(2):132-152. doi: 10.1002/1878-0261.12414. Epub 2018 Dec 21.
6
The chick chorioallantoic membrane (CAM) as a versatile patient-derived xenograft (PDX) platform for precision medicine and preclinical research.鸡胚绒毛尿囊膜(CAM)作为一种用于精准医学和临床前研究的多功能患者来源异种移植(PDX)平台。
Am J Cancer Res. 2018 Aug 1;8(8):1642-1660. eCollection 2018.
7
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics.卵巢癌免疫疗法:临床前模型与新兴疗法
Cancers (Basel). 2018 Jul 26;10(8):244. doi: 10.3390/cancers10080244.
8
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8.新型高级别浆液性卵巢癌细胞系 OVPA8 的建立与鉴定。
Int J Mol Sci. 2018 Jul 17;19(7):2080. doi: 10.3390/ijms19072080.
9
Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.鸡胚尿囊膜分析作为一种体内模型,用于研究基于纳米粒子的抗癌药物在卵巢癌中的作用。
Sci Rep. 2018 Jun 4;8(1):8524. doi: 10.1038/s41598-018-25573-8.
10
A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing.用于临床前测试的具有基因组特征的高级别浆液性卵巢癌异种移植物集合。
Am J Pathol. 2018 May;188(5):1120-1131. doi: 10.1016/j.ajpath.2018.01.019. Epub 2018 Feb 16.